Specifications
- Purity
- ≥98% (TLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- Soluble in ethanol (20mg/ml), DMSO or chloroform.
Category: Antibiotics
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
The tetracyclic triterpenoid is a fusidane antibiotic originally isolated from F. coccineum. It is active against the Gram-positive bacteria S. aureus, S. pyogenes, C. diphtheriae, B. subtilis, and C. tetani but not the Gram-negative bacteria E. coli, S. typhimurium, and P. vulgaris or the fungi C. albicans and A. fumigatus. This antibacterial agent inhibits bacterial protein synthesis by preventing the release of translation elongation factor G (EF-G) from ribosomes. Fusidic acid has immunomodulatory effects and inhibits the inhibitory and activating effects of interleukins IL-1 and IL-6 on glucose-induced insulin production and exhibits antidiabetic effects in a rat moδ Fusidic acid improves the symptoms of colitis in rats and inhibits the growth of Toxoplasma gondii and Listeria monocytogenes EGD in vitro, but not in mice.
| Synonyms | Ramycin, Fusidinic Acid, NSC 56192, SQ 16603 |
|---|---|
| Purity | ≥98% (TLC) |
| Appearance | White to off-white powder |
| CAS-Number | 6990-06-3 |
| Molecular Formula | C31H48O6 |
| Molecular Weight | 516.71 |
| Identity | 1H-NMR |
| Solvents | Soluble in ethanol (20mg/ml), DMSO or chloroform. |
| Smiles | OC(/C(CC/C=C(C)/C)=C1[C@@H](OC(C)=O)C[C@]2(C)[C@@]3(C)CC[C@@]4([H])[C@H](C)[C@H](O)CC[C@]4(C)[C@]3([H])[C@H](O)C[C@]2\1[H])=O |
| InChi Key | IECPWNUMDGFDKC-MZJAQBGESA-N |
| Shipping | AMBIENT |
| Short Term Storage | RT |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Hazard statements | H302 |
| Precautionary statements | P264 – P270 – P301 + P312 + P330 – P501 |
| GHS Symbol | GHS07 |
| Signal word | Warning |
| Transportation | Not dangerous goods |
| References | (1) W.O. Godtfredsen, et al.; Nature 193, 987 (1962), (2) N. Tanaka, et al.; Biochem. Biophys. Res. Commun. 30, 278 (1968), (3) L. Verbist; J. Antimicrob. Chemother. 25, 1 (1990), (4) K. Bendtzen, et al.; J. Endocrinol. 132, 345 (1992), (5) K. Buschard, et al.; Autoimmunity 14, 101 (1992), (6) J Turnidge, et al.; Int. J. Antimicrob. Agents 12, S23 (1999), (7) P. Collignon & L. Turnidge; Int. J. Antimicrob. Agents 12, S45 (1999), (8) K. Christiansen; Int. J. Antimicrob. Agents 12, S73 (1999), (9) A. Savelsbergh, et al.; RNA 15, 772 (2009) |
| InChi | InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1 |
| Quantity | 1 g, Bulk |

Flumorph